Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1672NIH 194INDUSTRY 158NETWORK 77OTHER_GOV 64UNKNOWN 15FED 5INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 8Barrett Esophagus 5Myasthenia Gravis 4Breast Neoplasms 4Leiomyoma 3Carcinoma, Hepatocellular 3Pancreatic Neoplasms 2Multiple Myeloma 2Lymphoma, Follicular 2Lung Neoplasms 2Lipoma 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma in Situ 2Warts 1Vaginosis, Bacterial 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Syphilis 1Sexually Transmitted Diseases 1Retroperitoneal liposarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pilonidal Sinus 1Papillomavirus Infections 1Overweight 1Ovarian Neoplasms 1Osteosarcoma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDIV × Rectal Neoplasms × Clear all
NCT01613469 2018-08-16

Maintenance Chemotherapy After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer

Marks, John, M.D.

Phase 2 Terminated
5 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡